Table 1.
Overview of All Primary Antipeptide Antisera Used in This Study
| Antibody | Dilution | Immunogen | Reference | Source |
|---|---|---|---|---|
| AST-A1 | 1:6,000 | APSGAQRLYGFGLa | Vitzthum et al., 46 | Dr. H. Agricola (Jena, Germany) |
| AT2 | 1:5,000 | GFKNVEMMTARGFa | Veenstra and Hagedorn, 42 | Dr. J. Veenstra (Bordeaux, France) |
| SIF3 | 1:1,000 | AYRKPPFNGSIFa | Terhzaz et al., 37 | Dr. J. Veenstra (Bordeaux, France) |
| FMRF4 | 1:2,000 | FMRFa | Marder et al., 15 | Dr. E. Marder (Brandeis Univ., USA) |
| MIP5 | 1:500 | GWQDLQGGWa | Predel et al., 25 | Dr. M. Eckert (Jena, Germany) |
| sNPF6 | 1:1,000 | PQRLRWa | Johard et al., 12 | Dr. J. Veenstra (Bordeaux, France) |
| TKRP7 | 1:1,000 | APSGFLGVRa | Winther and Nässel, 48 | Dr. D.R. Nässel (Stockholm, Sweden) |
1
All primary antisera were produced in rabbits.
2
allatostatin-A;
3
allatotropin;
4
Ser-Ile-Phe-amide;
5
Phe-Met-Arg-Phe-amide;
6
myoinhibitory peptide;
7
short neuropeptide F;
8
tachykinin-related peptides.